GD3- and O-acetylated GD3-gangliosides in the GM2 synthase-deficient mouse brain and their immunohistochemical localization

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 82, Issue 6, 2006, Pages 189-196

  Matsuda, Junko ^a,d   Vanier, Marie T ^b   Popa, Iuliana ^c   Portoukalian, Jacques ^c   Suzuki, Kunihiko ^a  

^a TOKAI UNIVERSITY   (Japan)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c UNIVERSITÉ DE LYON   (France)

^d Research Institute of Science and Technology   (Japan)

Author keywords

Ganglioside; GM2 synthase; Immunohistochemistry; Knockout mouse; O acetylated ganglioside; Sphingolipid

Indexed keywords

EID: 33751187332     PISSN: 03862208     EISSN: 03862208     Source Type: Journal    
DOI: 10.2183/pjab.82.189     Document Type: Article

References (46)

1. Nagata, Y., Yamashiro, S., Yodoi, J., Lloyd, K. O., Shiku, H., and Furukawa, K. (1992) Expression cloning of β1,4 N- acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J. Biol. Chem. 267, 12082-12089.
2. Sango, K., Johnson, O. N., Kozak, C. A., and Proia, R. L. (1995) β-1,4-N-acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene. Genomics 27, 362-365.
3. Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K. et al. (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 93, 10662-10667.
4. Liu, Y. J., Wada, R., Kawai, H., Sango, K., Deng, C. X., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U. et al. (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103, 497-505.
5. Sheikh, K. A., Sun, J., Liu, Y. J., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W., and Schnaar, R. L. (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. USA 96, 7532-7537.
6. Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K. et al. (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 93, 10662-10667.
7. Liu, Y. J., Wu, Y. P., Wada, R., Neufeld, E. B., Mullin, K. A., Howard, A. C., Pentchev, P. G., Vanier, M. T., Suzuki, K., and Proia, R. L. (2000) Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Hum. Mol. Genet. 9, 1087-1092.
8. Svennerholm, L. and Fredman, P. (1980) A procedure for the quantitative isolation of brain gangliosides. Biochim. Biophys. Acta 617, 97-109.
9. Svennerholm, L., Boström, K., Helander, C. G., and Jungbjer, B. (1991) Membrane lipids in the aging human brain. J. Neurochem. 56, 2051-2059.
10. Kyrklund, T. (1987) Two procedures to remove polar contaminants from a crude brain lipid extract by using prepacked reverse-phase columns. Lipids 22, 274-277.
11. Svennerholm, L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol- hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
12. Miettinen, T., and Takki-Luukkainen, I.-T. (1959) Use of butylacetate for determination of sialic acid. Acta Chem. Scand. 13, 856-858.
13. Cerato, E., Birkle, S., Portoukalian, J., Mezazigh, A., Chatal, J. F., and Aubry, J. (1997) Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives. Hybridoma 16, 307-316.
14. Ostrander, G. K., Bozlee, M., Fukuda, M., Dell, A., Thomas-Oates, J. E., Levery, S. B., Eaton, H. L., Hakomori, S., and Holmes, E. H. (1991) Isolation and characterization of the major glycosphingolipids from the liver of the rainbow trout (Oncorhynchus mykiss): identification of an abundant source of 9-O-acetyl GD3. Arch. Biochem. Biophys. 284, 413-421.
15. Portoukalian, J., and Bouchon, B. (1986) Hydrolysis of all gangliosides, including GM1 and GM2, on thin-layer plates by Vibrio cholerae neuraminidase. J. Chromatogr. 380, 386-392.
16. Goldman, J. E., Hirano, A., Yu, R. K., and Seyfried, T. N. (1984) GD3 ganglioside is a glycolipid characteristic of immature neuroectodermal cells. J. Neuroimmunol. 7, 179-192.
17. Schaal, H., Wille, C., and Wille, W. (1985) Changes of ganglioside pattern during cerebellar development of normal and staggerer mice. J. Neurochem. 45, 544-551.
18. Kotani, M., Kawashima, I., Ozawa, H., Ogura, K., Ishizuka, I., Terashima, T., and Tai, T. (1994) Immunohistochemical localization of minor gangliosides in the rat central nervous system. Glycobiology 4, 855-865.
19. Kotani, M., Terashima, T., and Tai, T. (1995) Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 700, 40-58.
20. Kotani, M., and Tai, T. (1997) An immunohistochemical technique with a series of monoclonal antibodies to gangliosides: their differential distribution in the rat cerebellum. Brain Res. Brain Res. Protoc. 1, 152-156.
21. Molander, M., Berthold, C. H., Persson, H., and Fredman, P. (2000) Immunostaining of ganglioside GD1b, GD3 and GM1 in rat cerebellum: Cellular layer and cell type specific associations. J. Neurosci. Res. 60, 531-542.
22. Yasuda, Y., Naito, T., Watarai, S., Fujita, S., and Kitamura, T. (2000) Ganglioside GD3 immunochemistry does not visualize microglia but astroglia. Acta Histochem. Cytochem. 33, 253-258.
23. Bektas, M. and Spiegel, S. (2003) Glycosphingolipids and cell death. Glycoconjugate J. 20, 39-47.
24. Colell, A., Morales, A., Fernández-Checa, J. C., and García-Ruiz, C. (2002) Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-α-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation - Possible role of ganglioside GD3. FEBS Lett. 526, 135-141.
25. García-Ruiz, C., Colell, A., París, R., and Fernández-Checa, J. C. (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J. 14, 847-858.
26. Malisan, F., Franchi, L., Tomassini, B., Ventura, N., Condò, I., Rippo, M. R., Rufini, A., Liberati, L., Nachtigall, C., Kniep, B. et al. (2002) Acetylation suppresses the proapoptotic activity of GD3 ganglioside. J. Exp. Med. 196, 1535-1541.
27. Malisan, F. and Testi, R. (2002) GD3 ganglioside and apoptosis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585, 179-187.
28. Melchiorri, D., Martini, F., Lococo, E., Gradini, R., Barletta, E., De Maria, R., Caricasole, A., Nicoletti, F., and Lenti, L. (2002) An early increase in the disialoganglioside GD3 contributes to the development of neuronal apoptosis in culture. Cell Death Differ. 9, 609-615.
29. Morales, A., Colell, A., Mari, M., García-Ruiz, C., and Fernández-Checa, J. C. (2003) Glycosphingolipids and mitochondria: Role in apoptosis and disease. Glycoconjugate J. 20, 579-588.
30. Saqr, H. E., Omran, O., Dasgupta, S., Yu, R. K., Oblinger, J. L., and Yates, A. J. (2006) Endogenous GD3 ganglioside induces apoptosis in U-1242 MG glioma cells. J. Neurochem. 96, 1301-1314.
31. Simon, B. M., Malisan, F., Testi, R., Nicotera, P., and Leist, M. (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ. 9, 758-767.
32. Tomassini, B., Malisan, F., Franchi, L., Nicolo, C., Brea-Calvo, G., Saito, T., and Testi, R. (2004) Calnexin suppresses GD3 synthase-induced apoptosis. FASEB J. 18, NIL75-NIL88.
33. Castiglione, M., Spinsanti, P., Iacovelli, L., Lenti, L., Martini, F., Gradini, R., Di, G. G., V., Caricasole, A., Caruso, A., De Maria, R. et al. (2004) Activation of Fas receptor is required for the increased formation of the disialoganglioside GD3 in cultured cerebellar granule cells committed to apoptotic death. Neuroscience 126, 889-898.
34. Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T., Nakano, J., Nakashima, H., Okuda, T., Mizutani, H., Hattori, H., Ueda, M. et al. (2005) Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. USA 102, 11041-11046.
35. Hedberg, K. M., Dellheden, B., Wikstrand, C. J., and Fredman, P. (2000) Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Glycoconjugate J. 17, 717-726.
36. París, R., Morales, A., Coll, O., Sánchez-Reyes, A., García-Ruiz, C., and Fernández-Checa, J. C. (2002) Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy. J. Biol. Chem. 277, 49870-49876.
37. Zeng, G. C., Gao, L. Y., Birklé, S., and Yu, R. K. (2000) Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60, 6670-6676.
38. Furukawa, K., Horie, M., Okutomi, K., Sugano, S., and Furukawa, K. (2003) Isolation and functional analysis of the melanoma specific promoter region of human GD3 synthase gene. Biochim. Biophys. Acta 1627, 71-78.
39. Birklé, S., Ren, S., Slominski, A., Zeng, G., Gao, L., and Yu, R. K. (1999) Down-regulation of the expression of O-acetyl-GD3 by the O-acetylesterase cDNA in hamster melanoma cells: Effects on cellular proliferation, differentiation, and melanogenesis. J. Neurochem. 72, 954-961.
40. Birklé, S., Gao, L. Y., Zeng, G. C., and Yu, R. K. (2000) Downregulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: Effects on cellular growth, melanogenesis, and dendricity. J. Neurochem. 74, 547-554.
41. Negreiros, E. M. A., Leao, A. C. M., Santiago, M. F., and Mendez-Otero, R. (2003) Localization of ganglioside 9-Oacetyl GD3 in point contacts of neuronal growth cones. J. Neurobiol. 57, 31-37.
42. Osanai, T., Kotani, M., Yuen, C. T., Kato, H., Sanai, Y., and Takeda, S. (2003) Immunohistochemical and biochemical analyses of GD3, GT1b, and GQ1b gangliosides during neural differentiation of P19 EC cells. FEBS Lett. 537, 73-78.
43. Santiago, M. F., Berredo-Pinho, M., Costa, M. R., Gandra, M., Cavalcante, L. A., and Mendez-Otero, R. (2001) Expression and function of ganglioside 9-O-acetyl GD3 in postmitotic granule cell development. Mol. Cell. Neurosci. 17, 488-499.
44. Santiago, M. F., Costa, M. R., and Mendez-Otero, R. (2004) Immunoblockage of 9-O-acetyl GD3 ganglioside arrests the in vivo migration of cerebellar granule neurons. J. Neurosci. 24, 474-478.
45. Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M., and Chapman, P. B. (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181.
46. Inoki, Y., Miura, T., Kajimoto, T., Kawase, M., Kawase, Y., Yoshida, Y., Tsuji, S., Kinouchi, T., Endo, H., Kagawa, Y. et al. (2000) Ganglioside GD3 and its mimetics induce cytochrome c release from mitochondria. Biochem. Biophys. Res. Commun. 276, 1210-1216.